nsc-141537 and Kidney-Neoplasms
nsc-141537 has been researched along with Kidney-Neoplasms* in 1 studies
Other Studies
1 other study(ies) available for nsc-141537 and Kidney-Neoplasms
Article | Year |
---|---|
Anguidine: a broad phase II study of the Southeastern Cancer Study Group.
Anguidine, a phase II agent, was used to treat 276 patients with solid tumors. The overall evaluability rate was 68%. Hematologic toxicity was substantial but not prohibitive. There were no complete responses, two partial responses, and 12 stabilizations. Topics: Adenocarcinoma; Breast Neoplasms; Drug Evaluation; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Neoplasms; Leukocyte Count; Lung Neoplasms; Melanoma; Platelet Count; Sesquiterpenes; Trichothecenes | 1984 |